Diana Isabel
Llopiz Khatchikian
Investigadora Asociada
Jesús María
Prieto Valtueña
Investigador hasta 2014
Publicaciones en las que colabora con Jesús María Prieto Valtueña (12)
2017
-
Blockage of FOXP3 transcription factor dimerization and FOXP3/AML1 interaction inhibits T regulatory cell activity: sequence optimization of a peptide inhibitor
Oncotarget, Vol. 8, Núm. 42, pp. 71709-71724
2015
-
Clinical testing of a dendritic cell targeted therapeutic vaccine in patients with chronic hepatitis C virus infection
Molecular Therapy - Methods and Clinical Development, Vol. 2, pp. 15006
2013
-
Helper cell-independent antitumor activity of potent CD8+ T cell epitope peptide vaccines is dependent upon CD40L
OncoImmunology, Vol. 2, Núm. 12, pp. 1-11
2011
-
Adjuvant combination and antigen targeting as a strategy to induce polyfunctional and high-avidity T-cell responses against poorly immunogenic tumors
Cancer Research, Vol. 71, Núm. 9, pp. 3214-3224
-
Improved dendritic cell-based immunization against hepatitis C virus using peptide inhibitors of interleukin 10
Hepatology, Vol. 53, Núm. 1, pp. 23-31
2010
-
A peptide inhibitor of FOXP3 impairs regulatory T cell activity and improves vaccine efficacy in mice
Journal of Immunology, Vol. 185, Núm. 9, pp. 5150-5159
2009
-
Peptide inhibitors of transforming growth factor-β enhance the efficacy of antitumor immunotherapy
International Journal of Cancer, Vol. 125, Núm. 11, pp. 2614-2623
2008
-
Combined immunization with adjuvant molecules poly(I:C) and anti-CD40 plus a tumor antigen has potent prophylactic and therapeutic antitumor effects
Cancer Immunology, Immunotherapy, Vol. 57, Núm. 1, pp. 19-29
-
In vitro and in vivo down-regulation of regulatory T cell activity with a peptide inhibitor of TGF-β1
Journal of Immunology, Vol. 181, Núm. 1, pp. 126-135
-
Vaccination against hepatitis C virus with dendritic cells transduced with an adenovirus encoding NS3 protein
Molecular Therapy, Vol. 16, Núm. 1, pp. 210-217
2007
-
Induction of potent and long-lasting CD4 and CD8 T-cell responses against hepatitis C virus by immunization with viral antigens plus poly(I:C) and anti-CD40
Antiviral Research, Vol. 74, Núm. 1, pp. 25-35
-
The extra domain A from fibronectin targets antigens to TLR4-expressing cells and induces cytotoxic T cell responses in vivo
Journal of Immunology, Vol. 178, Núm. 2, pp. 748-756